Congress moves to ban abortion pills by mail, overriding FDA approval
H.R. 9421 — Ban Abortion by Mail Act · Filed by Sheri Biggs (R-SC) · 9 cosponsors · Introduced Jun 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits doctors certified to prescribe mifepristone (the abortion pill) from doing so without an in-person visit with the patient and a medical license in the patient's state. Providers who violate either requirement lose their certification to prescribe the drug for at least 2 years. The bill effectively bans mail-order abortion medication by making remote prescribing illegal.
Why we flagged it
The bill's operative mechanism is a direct restriction on how a specific medication can be prescribed, targeting the telehealth delivery model. Despite framing around REMS safety protocols, the bill's functional effect is to eliminate mail-order abortion access.
What the text implies
- The in-person visit requirement may effectively require patients to travel to states where abortion is legal if their home state has banned the procedure, creating a de facto interstate travel barrier.
- The state-licensing requirement could prevent providers in states with legal abortion from serving patients in neighboring states, fragmenting the telehealth market and reducing access in rural areas.
The full analysis lists 4 implications of this text.
Who it affects
The bill restricts access to a medication approved by the FDA and currently available through telehealth in many states. Patients in states where providers lack licenses or who cannot travel for in-person visits lose access to a legal medical option, reducing reproductive autonomy and forcing some to travel interstate or forgo the procedure entirely.